Logo image of IX1.DE

IDEXX LABORATORIES INC (IX1.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:IX1 - US45168D1046 - Common Stock

612.6 EUR
+30.2 (+5.19%)
Last: 11/20/2025, 7:00:00 PM

IX1.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap50.16B
Revenue(TTM)3.84B
Net Income(TTM)866.24M
Shares81.88M
Float81.33M
52 Week High612.6
52 Week Low349.2
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)9.49
PE64.55
Fwd PE58.05
Earnings (Next)02-03 2025-02-03/amc
IPO1991-06-21
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


IX1.DE short term performance overview.The bars show the price performance of IX1.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60

IX1.DE long term performance overview.The bars show the price performance of IX1.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60

The current stock price of IX1.DE is 612.6 EUR. In the past month the price increased by 34.52%. In the past year, price increased by 21.26%.

IDEXX LABORATORIES INC / IX1 Daily stock chart

IX1.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
2M6.DE MEDTRONIC PLC 18.28 114.42B
1MDT.MI MEDTRONIC PLC 18.6 114.29B
SHL.DE SIEMENS HEALTHINEERS AG 17.79 47.97B
PHIA.AS KONINKLIJKE PHILIPS NV 16.23 23.13B
PHI1.DE KONINKLIJKE PHILIPS NV 16.07 22.90B
1PHIA.MI KONINKLIJKE PHILIPS NV 16.67 23.11B
BIM.PA BIOMERIEUX 28.39 12.97B
OBCK.DE OTTOBOCK SE & CO KGAA 160 4.81B
AFX.DE CARL ZEISS MEDITEC AG - BR 26.96 4.12B
DIA.MI DIASORIN SPA 18.27 3.38B
DRW3.DE DRAEGERWERK AG - PREF 10.83 1.31B
DRW8.DE DRAEGERWERK AG 9.46 1.14B

About IX1.DE

Company Profile

IX1 logo image IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.

Company Info

IDEXX LABORATORIES INC

One Idexx Drive

Westbrook MAINE US

Employees: 11000

IX1 Company Website

Phone: 12075560300

IDEXX LABORATORIES INC / IX1.DE FAQ

What does IDEXX LABORATORIES INC do?

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.


Can you provide the latest stock price for IDEXX LABORATORIES INC?

The current stock price of IX1.DE is 612.6 EUR. The price increased by 5.19% in the last trading session.


Does IX1 stock pay dividends?

IX1.DE does not pay a dividend.


What is the ChartMill rating of IDEXX LABORATORIES INC stock?

IX1.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


On which exchange is IX1.DE stock listed?

IX1.DE stock is listed on the Frankfurt Stock Exchange exchange.


What is the employee count for IX1 stock?

IDEXX LABORATORIES INC (IX1.DE) currently has 11000 employees.


IX1.DE Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to IX1.DE. When comparing the yearly performance of all stocks, IX1.DE is one of the better performing stocks in the market, outperforming 92.16% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IX1.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to IX1.DE. IX1.DE gets an excellent profitability rating and is at the same time showing great financial health properties.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IX1.DE Financial Highlights

Over the last trailing twelve months IX1.DE reported a non-GAAP Earnings per Share(EPS) of 9.49. The EPS increased by 11.73% compared to the year before.


Industry RankSector Rank
PM (TTM) 22.53%
ROA 25.85%
ROE 53.54%
Debt/Equity 0.48
Chartmill High Growth Momentum
EPS Q2Q%10.67%
Sales Q2Q%6.56%
EPS 1Y (TTM)11.73%
Revenue 1Y (TTM)7.16%

IX1.DE Forecast & Estimates

20 analysts have analysed IX1.DE and the average price target is 501.57 EUR. This implies a price decrease of -18.13% is expected in the next year compared to the current price of 612.6.

For the next year, analysts expect an EPS growth of 6.94% and a revenue growth 6.29% for IX1.DE


Analysts
Analysts74
Price Target501.57 (-18.12%)
EPS Next Y6.94%
Revenue Next Year6.29%

IX1.DE Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A